A carregar...
As Technologies for Nucleotide Therapeutics Mature, Products Emerge
The long path from initial research on oligonucleotide therapies to approval of antisense products is not unfamiliar. This lag resembles those encountered with monoclonal antibodies, gene therapies, and many biological targets and is consistent with studies of innovation showing that technology matu...
Na minha lista:
| Publicado no: | Mol Ther Nucleic Acids |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American Society of Gene & Cell Therapy
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5686430/ https://ncbi.nlm.nih.gov/pubmed/29246316 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.omtn.2017.10.017 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|